Medtronic plc (MDT) earnings on September 1, 2026

Before the market opens Q2 2026

More Medtronic plc earnings

Prior outlook: Optimistic Outcome: Accurate

Medtronic jumped early after reporting strong quarterly results, but lost most of those gains by the end of market review.

MDT price around the earnings

92.04

Change: +1.5%

2026-09-01, 20:00 UTC

Start of the measured window End of the measured window
90.65 93.42 96.20 98.97 90.65
Price series around the eventClosing price per minute from before the event to the end of the measured window.
September 1, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Optimistic Outcome: Accurate

Thesis published
Results released

Strong analyst backing, earnings beat expectations in recent quarters, scenario points optimistic

Analysts strongly support this stock with a Buy rating and a price target about 9% above current levels. The company's earnings have beaten expectations in recent quarters, and recent price gains (+6.18% in 30 days) outpace the broader market — the technical strength outweighed weaker crowd sentiment.

Context analyzed before publication

Summary
Strong analyst backing, earnings beat expectations in recent quarters, scenario points optimistic
Playbook
The stock's 30-day performance (+6.18%) beats the market index, and the current price sits above a key resistance level. Analyst scores jumped dramatically in one day (from 16 to 51), showing heightened conviction ahead of an earnings event.
Trend
Expert confidence surged sharply in one session

Analysts

Drivers

  • Analysts Positive

    Analysts give a strong buy rating with 25 opinions and cite a target price about 9% above the current level. The company has a strong recent record of beating earnings expectations, with an average surprise of +2.1%.

Evidence

Analyst consensus
Buy
Consensus average (1-5)
1.72
Analysts covering the stock
25
Average price target
98.84
Lowest price target
78
Highest price target
121
Upside to price target
9%
Quarterly earnings growth
17.8%
Revenue growth
9.9%
Forward EPS
6.4
Trailing EPS
3.71
Analyst moves in the last 60 days
4
  • Strong buy: 3
  • Buy: 17
  • Hold: 9
  • Sell: 0
  • Strong sell: 0
Strong buy
3
Buy
17
Hold
9
Sell
0
Strong sell
0
  • August 18, 2026 · BTIG: Reiterates rating (Buy → Buy)
  • July 28, 2026 · UBS: Upgrades rating (Neutral → Buy)
  • July 10, 2026 · TD Cowen: Maintains rating (Buy → Buy)
  • July 6, 2026 · Evercore ISI Group: Maintains rating (Outperform → Outperform)

News and sentiment

Drivers

  • News & sentiment Neutral

    News coverage is balanced, mainly noting MDT in coverage without strong directional news.

Evidence

Sentiment
Sentiment
Constructive
Mention volume
High
Normalized volume
99%
News
Sources (6)

Technicals

Drivers

  • Technical Positive

    The stock's 30-day gain of +6.18% beats the market index's +2.69% by a significant margin. The current price ($91.76) sits above the nearest resistance level ($90.80).

Evidence

Price when the context was analyzed
90.68
Average true range (ATR)
2%
Distance to 52-week high
-11.8%
14-day change (14d)
+0.1%
30-day change (31d)
+6.2%
30-day relative strength
+3.5%
SPY change (31d)
+2.7%
Nearest support
90.28
Distance to nearest support
0.4%
Nearest resistance
90.8
Distance to nearest resistance
0.1%
Volume accumulation ratio (14d / 46d)
0.76
  • Major: 90.28 (0.4% away, 0.23 ATR, 48 touches)
  • Major: 89.24 (1.6% away, 0.81 ATR, 39 touches)
  • Major: 88.61 (2.3% away, 1.16 ATR, 51 touches)
  • Major: 90.8 (0.1% away, 0.07 ATR, 23 touches)
  • Major: 91.78 (1.2% away, 0.62 ATR, 47 touches)
  • Major: 92.49 (2% away, 1.02 ATR, 29 touches)

Trends

Evidence

Average earnings surprise
+2.1%
  • June 3, 2026: actual EPS 1.55 vs estimate 1.54 (surprise +0.6%)
  • February 17, 2026: actual EPS 1.36 vs estimate 1.34 (surprise +1.9%)
  • November 18, 2025: actual EPS 1.36 vs estimate 1.31 (surprise +3.5%)
  • August 19, 2025: actual EPS 1.26 vs estimate 1.23 (surprise +2.5%)

Expected move

Implied move
+4.0%
Source
Options chain

Reactions over its last 20 earnings

Median move
3.2%
75th percentile move
4.8%
90th percentile move
5.8%
Up / down moves
9 / 11
Average up move
+3.0%
Average down move
-4.2%

Monitoring and close

What Medtronic plc reported

Status
Finished
Actual EPS1.45
EPS estimate1.39
EPS surprise+4.5%

Medtronic Q1 2027 earnings call transcript released. Prior quarter showed beat driven by growth across businesses, with $700 million Cornerstone Robotics investment announced.

Sources (34)

Pre-market second reading after the results

There is no second reading available for this event.

How the stock reacted

Outcome
Accurate
Consolidated
+1.6%
Max favorable move (MFE)
9.7%
Max adverse move (MAE)
0%